World Equity Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
APM
World Equity Group's ARKG Position: Q2 2022 in Review
World Equity Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 4,398 shares — an estimated $202K sold.
World Equity Group first reported a position in ARKG in Q1 2022 and held it in 1 quarter. The position peaked at $202K in Q1 2022. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.
- World Equity Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
- World Equity Group sold 4,398 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $202K.
- World Equity Group first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 1 quarter.
- World Equity Group's ARK Genomic Revolution ETF position peaked at $202K in Q1 2022.
- 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.
Based on World Equity Group's 13F filing for Q2 2022, filed 6 Sep 2024.